Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0JQAJB
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
MGTA-117
|
|||||
| Synonyms |
Anti-CD117 amanitin ADC; Anti-CD117 amanitin antibody drug conjugate; CD117-amanitin antibody drug conjugate; MGTA 117; MGTA-117; anti-CD117 (c-KIT)-amanitin antibody-drug conjugate; CD117-ADC
Click to Show/Hide
|
|||||
| Organization |
Heidelberg Pharma AG
|
|||||
| Drug Status |
Phase 1 (Terminated)
|
|||||
| Indication |
In total 2 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
2
|
|||||
| Antibody Name |
Opelkibart
|
Antibody Info | ||||
| Antigen Name |
Mast/stem cell growth factor receptor Kit (KIT)
|
Antigen Info | ||||
| Payload Name |
Alpha-amanitin
|
Payload Info | ||||
| Therapeutic Target |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Undisclosed
|
|||||
| Combination Type |
elmanitin
|
|||||
